| Identification | Back Directory | [Name]
GSK-1440115 | [CAS]
1003878-16-7 | [Synonyms]
GSK-1440115
[1,1'-Biphenyl]-4-carboxylic acid, 4'-[(1R)-1-[[2-(6,7-dichloro-2,3-dihydro-3-oxo-4H-1,4-benzoxazin-4-yl)acetyl]methylamino]-2-(4-morpholinyl)ethyl]- | [Molecular Formula]
C30H29Cl2N3O6 | [MDL Number]
MFCD30738669 | [MOL File]
1003878-16-7.mol | [Molecular Weight]
598.47 |
| Hazard Information | Back Directory | [Uses]
GSK-1440115 is an antagonist of the Urotensin II Receptor with an IC50 value of 82.3 nM[1]. | [References]
[1] Tae-Ho Kim, et al. A Novel Urotensin II Receptor Antagonist, KR-36996 Inhibits Smooth Muscle Proliferation through ERK/ROS Pathway. Biomol Ther (Seoul). 2017 May 1;25(3):308-314. DOI:10.4062/biomolther.2016.219 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.bocsci.com |
|